Telemetry Investments, L.L.C. Regeneron Pharmaceuticals, Inc. Transaction History

Telemetry Investments, L.L.C.

  • $63.3 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$478.3 - $607.98 $1.2 Million - $1.52 Million
-2,500 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $1.23 Million - $1.61 Million
2,500 New
2,500 $1.56 Million
Q3 2018

Nov 14, 2018
SELL
$351.14 - $408.51 $316,026 - $367,659
-900 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $256,140 - $310,491
900 New
900 $310,000

Others Institutions Holding REGN

# of Institutions
1,463
Shares Held
84.5M
Call Options Held
907K
Put Options Held
1.3M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $111B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Telemetry Investments, L.L.C. Portfolio

Follow Telemetry Investments, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email